View Single Post
Old 12-15-2009, 05:01 PM   #13
Jackie07
Senior Member
 
Jackie07's Avatar
 
Join Date: Jan 2008
Location: "Love never fails."
Posts: 5,809
Re: Cumulative Radiation Risk -- Don't tell me I'm crying wolf

Found this study while trying to locate the citation of the article on the first post:


Cancer Risks and Radiation Exposure From Computed Tomographic Scans
How Can We Be Sure That the Benefits Outweigh the Risks?
Rita F. Redberg, MD, MSc

Arch Intern Med. 2009;169(22):2049-2050.

The introduction of the computed tomographic (CT) scanner ushered in a new era of internal medicine diagnosis. Conditions that once required laparoscopy for diagnosis could now be diagnosed on the radiology reading board. The previously opaque anatomy of the living brain could now be visualized. The best part was that the test was "noninvasive," fast, and painless. With the exception of patients who were allergic to dye or had renal insufficiency, CT was considered completely safe. No wonder it had such a significant effect on the practice of medicine.

Two articles in this issue of the Archives make us question if we have gotten carried away in our enthusiasm. Every day, more than 19 500 CT scans are performed in the United States, subjecting each patient to the equivalent of 30 to 442 chest radiographs per scan. Whether these scans will lead to demonstrable benefits through improvements in longevity or quality of life is hotly debated. What is becoming clear, however, is that the large doses of radiation from such scans will translate, statistically, into additional cancers. With CT scan use increasing annually, it is imperative that clinicians take into account the radiation risks when assessing the benefit to their patients.

The number of CT scans is remarkable: a recent study of nearly 1 million nonelderly adults showed that 70% received CT scans during the 3-year period of study (2005-2007).1 There were an estimated 72 million CT scans conducted in 2007 alone.2 The doses of radiation from them also are eye opening. Although most patients receive relatively low doses from their scans, nearly 20% of the study's population received "moderate" exposures of between 3 and 20 mSv, and some 2% (translating to as many as 1.4 million patients nationwide) were exposed to "high" and "very high" doses of 20 mSv to more than 50 mSv.

What risks, then, are posed by radiation exposure from CT scans, and are such risks justified?
Two studies in this issue of the Archives help inform this discussion by providing actual effective radiation doses in the most commonly used CT scans and the cancer risks associated with this radiation. Smith-Bindman and colleagues3 collected actual data on radiation dosages for the most commonly used CT scans at 4 institutions in the San Francisco Bay area in California in 2008. They found a surprising variation in radiation dose—a mean 13-fold variation between the highest and lowest dose for each CT type studied (range, 6- to 22-fold difference across study types). There was no discernable pattern to the variation, which occurred within and across institutions. The investigators found a median effective dose of 22 mSv from a typical CT coronary angiogram and 31 mSv for a multiphase abdomen-pelvis CT scan. At one institution, exposure was a staggering 90 mSv for a multiphase abdomen-pelvis CT scan.

Even the median doses are 4 times higher than they are supposed to be, according to the currently quoted radiation dose for these tests. Just 1 CT coronary angiogram, on average, delivers the equivalent of 309 chest radiographs. From their data, Smith-Bindman et al3 estimated the risk of cancer, taking into consideration age, sex, and study type. By their calculations, 1 in every 270 forty-year-old women undergoing a CT coronary angiogram will develop cancer from the procedure.
In a second study, Berrington de González and colleagues2 determined CT scan use frequency using data from a large commercial insurance database, Medicare claims data, and IMV Medical Information Division survey data. They estimated there were 72 million CT scans performed in 2007. Excluding scans conducted after a diagnosis of cancer and those performed in the last 5 years of life, Berrington de González et al2 projected 29 000 excess cancers as a result of the CT scans done in 2007. These cancers will appear in the next 20 to 30 years and by the authors' estimates, at a 50% mortality rate, will cause approximately 15 000 deaths annually.

In other words, 15 000 persons may die as a direct result of CT scans physicians had ordered in 2007 alone. Presumably, as the number of CT scans increase from the 2007 rate, the number of excess cancers also will increase. In light of these data, physicians (and their patients) cannot be complacent about the hazards of radiation or we risk creating a public health time bomb.

The effort to avoid unnecessary excess cancers must be multifaceted. First, radiation protocols should be improved to eliminate the 13-fold difference in radiation dose for the same CT scan; exposures will be significantly reduced if all institutions were to use the lowest-dose technique. Smith-Bindman and colleagues3 found, for example, that the "usual" protocol sometimes unwittingly increased radiation. The authors offer several techniques to improve the quality of CT scans. In addition, patients should be fully informed about the radiation risk; it is unlikely that many patients now appreciate that a single CT scan may represent the radiation equivalent of hundreds of chest radiographs.

A popular current paradigm for health care presumes that more information, more testing, and more technology inevitably leads to better care. The studies by Berrington de González et al2 and Smith-Bindman et al3 counsel a reexamination of that paradigm for nuclear imaging. In addition, it is certain that a significant number of CT scans are not appropriate. A recent Government Accountability Office report on medical imaging, for example, found an 8-fold variation between states on expenditures for in-office medical imaging; given the lack of data indicating that patients do better in states with more imaging and given the highly profitable nature of diagnostic imaging, the wide variation suggests that there may be significant overuse in parts of the country.4 For example, a pilot study found that only 66% of nuclear scans were appropriate using American College of Cardiology criteria—the remainder were inappropriate or uncertain.5

The articles in this issue make clear that there is far more radiation from medical CT scans than has been recognized previously, in amounts projected to cause tens of thousands of excess cancers annually. Also, as these scans have become more sensitive, incidental findings lead to additional testing (and often more radiation), biopsies, and anxiety. Although a guiding principle in medicine is to ensure that the benefit of a procedure or therapy outweighs the risk, the explosion of CT scans in the past decade has outpaced evidence of their benefit. Although there are clear instances when CT scans help determine the treatment course for patients, more and more often patients go directly from the emergency department to the CT scanner even before they are seen by a physician or brought to their hospital room. To avoid unnecessarily increasing cancer incidence in future years, every clinician must carefully assess the expected benefits of each CT scan and fully inform his or her patients of the known risks of radiation.

AUTHOR INFORMATION
Correspondence: Dr Redberg, Editor, Archives of Internal Medicine, University of California, San Francisco, 505 Parnassus, M1180, San Francisco, CA 94143-0124 (redberg@medicine.ucsf.edu ).
Financial Disclosure: None reported.

REFERENCES
1. Fazel R, Krumholz HM, Wang Y; et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med. 2009;361(9):849-857. FREE FULL TEXT
2. Berrington de González A, Mahesh M, Kim K-P; et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 2009;169(22):2071-2077. FREE FULL TEXT
3. Smith-Bindman R, Lipson J, Marcus R; et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med. 2009;169(22):2078-2086. FREE FULL TEXT
4. US Government Accountability Office. Medicare Part B Imaging Services: Rapid Spending Growth and Shift to Physician Offices Indicate Need for CMS to Consider Additional Management Practices. Washington, DC: US Government Accountability Office; June 2008:21-22. Publication GAO-08-452. http://www.gao.gov/new.items/d08452.pdf. Accessed September 27, 2009.
5. Hendel RC. Evolving concepts of cardiac SPECT, PET, and CT: appropriateness criteria for SPECT/CT. http://www.acc.org/education/program...l%20ac%202.pdf. Accessed October 28, 2009.

CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?

RELATED ARTICLES

Projected Cancer Risks From Computed Tomographic Scans Performed in the United States in 2007
Amy Berrington de González, Mahadevappa Mahesh, Kwang-Pyo Kim, Mythreyi Bhargavan, Rebecca Lewis, Fred Mettler, and Charles Land
Arch Intern Med. 2009;169(22):2071-2077.
ABSTRACT | FULL TEXT
Radiation Dose Associated With Common Computed Tomography Examinations and the Associated Lifetime Attributable Risk of Cancer
Rebecca Smith-Bindman, Jafi Lipson, Ralph Marcus, Kwang-Pyo Kim, Mahadevappa Mahesh, Robert Gould, Amy Berrington de González, and Diana L. Miglioretti
Arch Intern Med. 2009;169(22):2078-2086.
ABSTRACT | FULL TEXT
__________________
Jackie07
http://www.kevinmd.com/blog/2011/06/doctors-letter-patient-newly-diagnosed-cancer.html
http://www.asco.org/ASCOv2/MultiMedi...=114&trackID=2

NICU 4.4 LB
Erythema Nodosum 85
Life-long Central Neurocytoma 4x5x6.5 cm 23 hrs 62090 semi-coma 10 d PT OT ST 30 d
3 Infertility tmts 99 > 3 u. fibroids > Pills
CN 3 GKRS 52301
IDC 1.2 cm Her2 +++ ER 5% R. Lmptmy SLNB+1 71703 6 FEC 33 R Tamoxifen
Recc IIB 2.5 cm Bi-L Mast 61407 2/9 nds PET
6 TCH Cellulitis - Lymphedema - compression sleeve & glove
H w x 4 MUGA 51 D, J 49 M
Diastasis recti
Tamoxifen B. scan
Irrtbl bowel 1'09
Colonoscopy 313
BRCA1 V1247I
hptc hemangioma
Vertigo
GI - > yogurt
hysterectomy/oophorectomy 011410
Exemestane 25 mg tab 102912 ~ 101016 stopped due to r. hip/l.thigh pain after long walk
DEXA 1/13
1-2016 lesions in liver largest 9mm & 1.3 cm onco. says not cancer.
3-11 Appendectomy - visually O.K., a lot of puss. Final path result - not cancer.
Start Vitamin D3 and Calcium supplement (600mg x2)
10-10 Stopped Exemestane due to r. hip/l.thigh pain OKed by Onco 11-08-2016
7-23-2018 9 mm groundglass nodule within the right lower lobe with indolent behavior. Due to possible adenocarcinoma, Recommend annual surveilence.
7-10-2019 CT to check lung nodule.
1-10-2020 8mm stable nodule on R Lung, two 6mm new ones on L Lung, a possible lymph node involvement in inter fissule.
"I WANT TO BE AN OUTRAGEOUS OLD WOMAN WHO NEVER GETS CALLED AN OLD LADY. I WANT TO GET SHARP EDGED & EARTH COLORED, TILL I FADE AWAY FROM PURE JOY." Irene from Tampa

Advocacy is a passion .. not a pastime - Joe

Last edited by Jackie07; 12-15-2009 at 05:06 PM..
Jackie07 is offline   Reply With Quote